Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia
- 1 April 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (7) , 523-533
- https://doi.org/10.1038/sj.gt.3301436
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 54 references indexed in Scilit:
- Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and InfarctionNew England Journal of Medicine, 2000
- Genentech enlightens other angiogenesis programsNature Biotechnology, 1999
- Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent MiceHuman Gene Therapy, 1997
- Manipulating AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinProceedings of the National Academy of Sciences, 1996
- Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.Proceedings of the National Academy of Sciences, 1996
- Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscleNature Medicine, 1995
- Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.Proceedings of the National Academy of Sciences, 1994
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factorJournal of Vascular Surgery, 1992